Evidence Synthesis
AARTIDRUGS posted a strong quarterly update, with its Gross Margin accelerating to 37.52%, up from 11.46%.
Loading stock analysis…
Loading stock analysis…
Evidence Synthesis
Last synthesized: 18 Sept 2026, 00:04
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence Synthesis
AARTIDRUGS posted a strong quarterly update, with its Gross Margin accelerating to 37.52%, up from 11.46%.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 37.52 % | 11.46 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 11.46 % | 7.14 | ▲ |
| REVENUE_GROWTH_YOY | 19 % | -6.9 | ▲ |
| EPS_ACTUAL | 4.95 INR | 5.663 | ▼ |
| EPS_SURPRISE_PERCENT | 0.01 % | 0.049 | ▼ |
| PRICE_CHANGE_PERCENT | 0.955 % | — | - |
| DAILY_VOLUME | 1,20,292 shares | 2,06,783 | ▼ |
| CLOSE_PRICE | 428.35 INR | 424.3 | ▲ |
| NEWS_SENTIMENT_SCORE | 1 score | — | - |
| ANALYST_STRONG_BUY_COUNT | 1 count | 0 | ▲ |
| TARGET_PRICE_PREMIUM | 10.66 % | — | - |